RF Capital Group Inc. buy krebskrebs
Start price
29.06.20
/
50%
€8.05
Target price
04.11.21
€10.00
Performance (%)
77.64%
End price
05.11.21
€14.30
Summary
This prediction ended on 05.11.21 with a price of €14.30. The BUY prediction by krebskrebs for RF Capital Group Inc. saw massive gains of 77.64%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| RF Capital Group Inc. | -2.469% | -2.469% | -37.632% | -68.816% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by krebskrebs for this prediction
In the thread RF Capital Group Inc. diskutieren
In the thread Trading RF Capital Group Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten